The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(4-(2-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-1-ylamino)phenyl)acetamide ID: ALA4576794
PubChem CID: 142487500
Max Phase: Preclinical
Molecular Formula: C22H22N4O2
Molecular Weight: 374.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccccc1-c1nnc(Nc2ccc(CC(N)=O)cc2)c2c1CCC2
Standard InChI: InChI=1S/C22H22N4O2/c1-28-19-8-3-2-5-18(19)21-16-6-4-7-17(16)22(26-25-21)24-15-11-9-14(10-12-15)13-20(23)27/h2-3,5,8-12H,4,6-7,13H2,1H3,(H2,23,27)(H,24,26)
Standard InChI Key: HCLMHNUCNNBTLD-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
33.4168 -11.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4156 -12.5202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1237 -12.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8333 -12.5197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8305 -11.6971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1219 -11.2918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5417 -12.9272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.2487 -12.5175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1235 -13.7463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1235 -15.3780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8336 -14.9652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8307 -14.1501 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.1244 -16.1952 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8325 -16.6030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8319 -17.4180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5393 -17.8257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2475 -17.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2440 -16.5949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5361 -16.1908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9562 -17.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6629 -17.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3716 -17.8198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6609 -16.5957 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4120 -14.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4162 -14.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6411 -13.8972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1578 -14.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6343 -15.2181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
3 9 1 0
9 25 2 0
24 10 2 0
10 11 1 0
11 12 2 0
12 9 1 0
10 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.44Molecular Weight (Monoisotopic): 374.1743AlogP: 3.41#Rotatable Bonds: 6Polar Surface Area: 90.13Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.50CX LogP: 3.52CX LogD: 3.52Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -0.88
References 1. Tsuji T, Yamaguchi M, Kuroyanagi J, Furuzono S, Konishi M, Terayama K, Tanaka J, Saito M, Kobayashi Y.. (2019) Discovery of novel pyridazine derivatives as glucose transporter type 4 (GLUT4) translocation activators., 29 (14): [PMID:31101471 ] [10.1016/j.bmcl.2019.05.013 ]